课题基金 / 基金详情

Screening for causative genes in unknown hemolytic anemia

Screening for causative genes in unknown hemolytic anemia
未知溶血性贫血致病基因的筛查
批准号:
17591013
负责人:
FUJII Hisaichi
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

FUJII Hisaichi的其他基金

相似基金

相关文献

中文摘要
翻译
α-血红蛋白稳定蛋白能与α-血红蛋白特异结合,防止其在红细胞中沉淀。AHSP作为分子伴侣在不稳定的游离α-珠蛋白单体的稳定过程中起着重要的作用,它会产生活性氧物种,导致红细胞蛋白质和脂质的损伤。为了验证AHSP基因缺陷可能是Heinz小体阳性贫血或感染或用药引发的急性溶血性贫血的原因,我们进行了一项病例对照研究,检测了28例溶血性贫血患者和95例对照的7个单核苷酸多态性(SNPs),发现人类AHSP基因的某个单倍型与未知溶血性贫血的一个亚群有显著关联。该单倍型包括4个SNPs(-557G、-465T、-201G和+248A)和位于AHSP基因5‘侧翼区的缺失插入多态(DIP)T15,报告基因分析表明该单倍型约占对照单倍型转录活性的23%。体外诱变分析表明,SNP-201G和T15都是AHSP基因转录活性降低的原因。我们的结论是,AHSP基因与一组Heinz体阳性RBC或感染/药物诱导的溶血性贫血的疾病易感性有关,并且-201A/T15纯合子更容易受到氧化应激的影响。
英文摘要
Alpha-hemoglobin stabilizing protein (AHSP) binds specifically to α-hemoglobin, and prevents its precipitation in red blood cells (RBC). AHSP plays an important role as a molecular chaperone in the stabilization of unstable free α-globin monomer, which generates reactive oxygen species, resulting in damage to red cell protein and lipids. To examine that AHSP gene defects might account for either Heinz body-positive anemia or acute hemolytic anemia triggered by infection or drug administration, we performed a case-control study by examining seven SNPs (single nucleotide polymorphisms) of 28 hemolytic anemia patients and 95 controls, and found that a certain haplotype of the human AHSP gene had significant association with a subgroup of unknown hemolytic anemia. The haplotype included four SNPs (-557G,-465T,-201G and +248A) and a deletion-insertion polymorphism (DIP), T15, in 5'-flanking region of AHSP gene, and a reporter gene assay showed that the haplotype accounts for about 23% transcriptional activity of a control haplotype. In vitro mutagenesis analysis revealed that both the SNP-201G and T15 are responsible for decreased transcriptional activity of AHSP gene. We conclude that the AHSP gene is correlated to disease-susceptibility in a group of hemolytic anemia with either Heinz body-positive RBC or infection/drug-induced episodes, and that the homozygotes of-201A/T15 are more susceptible to oxidative stress.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3324/haematol.10945
发表时间: 2007-06-01
期刊: HAEMATOLOGICA
影响因子: 10.1
作者: [Kanno, Hitoshi, Utsugisawa, Taiju, Fujii, Hisaichi]
通讯作者: Fujii, Hisaichi
寿命を終えた赤血球の処理機構~赤血球膜に出現する貪食目印分子に関する最近の知見~
生命末期红细胞的处理机制~红细胞膜上出现的吞噬标记分子的最新发现~
DOI: --
发表时间: 2007
期刊: Membrane 31・3(in press)
影响因子: --
作者: [菅野 仁, 藤井 寿一]
通讯作者: 藤井 寿一
Biochemical and molecular basis of red blood cell pyrimidine5'-nucleotidase deficiency
红细胞嘧啶5-核苷酸酶缺乏症的生化和分子基础
DOI: --
发表时间: 2006
期刊: Genetic Errors Associated with Purine and Pyrimidine Metabolism in Humans : Diagnosis and Treatment
影响因子: --
作者: [Xian M, et al., Hitoshi Kanno]
通讯作者: Hitoshi Kanno
DOI: 10.1016/j.exphem.2005.07.008
发表时间: 2005-11-01
期刊: EXPERIMENTAL HEMATOLOGY
影响因子: 2.6
作者: [Aizawa, S, Harada, T, Fujii, H]
通讯作者: Fujii, H
共 8 条
    MOLECULAR BASIS OF PYRIMIDINE 5'-NUCLEOTIDASE (P5N) DEFICIENCY AND FUNCTIONAL ANALYSIS OF P5N
    • 批准号:
      14571001
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2002
    • 负责人:
      FUJII Hisaichi
    • 依托单位:
    Molecular analysis of hereditary hemolytic anemia due to red cell enzyme anomalies
    • 批准号:
      10670971
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1998
    • 负责人:
      FUJII Hisaichi
    • 依托单位:
    海外基金